{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:04:54Z","timestamp":1771002294795,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.breast.2026.104697","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:17:28Z","timestamp":1768061848000},"page":"104697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Perceived financial toxicity after active treatment and its association with clinical outcomes among breast cancer survivors: A prospective cohort study"],"prefix":"10.1016","volume":"85","author":[{"given":"Doyoun","family":"Woen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Jin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Joo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Min","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong Ki","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1630-1783","authenticated-orcid":false,"given":"Se Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2026.104697_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.7987","article-title":"Financial toxicity of cancer treatment","author":"Hussaini","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2026.104697_bib2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.6004\/jnccn.2017.0161","article-title":"Distress and financial distress in adults with cancer: an age-based analysis","volume":"15","author":"Meeker","year":"2017","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.breast.2026.104697_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study","volume":"11","author":"Zafar","year":"2015","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.breast.2026.104697_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/cncr.27848","article-title":"Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer","volume":"119","author":"Davidoff","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2026.104697_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2026.104697_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/imt-2020-0030","article-title":"Economic burden of patients with advanced non-small-cell lung cancer receiving nivolumab versus chemotherapy in China","volume":"12","author":"Chai","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.breast.2026.104697_bib7","unstructured":"S. Andreas, C. Chouaid, S. Danson, O. Siakpere, L. Benjamin, R. Ehness, et al. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: a retrospective observational study (LuCaBIS)."},{"key":"10.1016\/j.breast.2026.104697_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-017133","article-title":"The financial toxicity of cancer: unveiling global burden and risk factors - a systematic review and meta-analysis","volume":"10","author":"Kitaw","year":"2025","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.breast.2026.104697_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.21037\/atm.2018.03.28","article-title":"Financial toxicity and implications for cancer care in the era of molecular and immune therapies","volume":"6","author":"Tran","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.breast.2026.104697_bib10","first-page":"137","article-title":"Financial toxicity among people with metastatic cancer: findings from the Cancer Experience Registry","volume":"32","author":"Mollica","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.breast.2026.104697_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/hsc.12907","article-title":"\u2018It was a big monetary cut\u2019\u2014A qualitative study on financial toxicity analysing patients' experiences with cancer costs in Germany","volume":"28","author":"Lueckmann","year":"2020","journal-title":"Health Soc Care Community"},{"key":"10.1016\/j.breast.2026.104697_bib12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11136-024-03599-y","article-title":"Social support during re-entry period and long-term quality of life in breast cancer survivors: a 10-year longitudinal cohort study","volume":"33","author":"Cho","year":"2024","journal-title":"Qual Life Res"},{"key":"10.1016\/j.breast.2026.104697_bib13","article-title":"Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial","author":"Johansson","year":"2024","journal-title":"JNCI: J Nat Cancer Inst"},{"key":"10.1016\/j.breast.2026.104697_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.11673","article-title":"Adherence to cancer prevention lifestyle recommendations before, during, and 2 years after treatment for high-risk breast cancer","volume":"6","author":"Cannioto","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.breast.2026.104697_bib15","article-title":"Financial toxicity of cancer care: it's time to intervene","volume":"108","author":"Zafar","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2026.104697_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2011.39.7406","article-title":"What happens now? Psychosocial care for cancer survivors after medical treatment completion","volume":"30","author":"Stanton","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2026.104697_bib17","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/cncr.21246","article-title":"Promoting adjustment after treatment for cancer","volume":"104","author":"Stanton","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2026.104697_bib18","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1016\/j.ijrobp.2024.07.947","article-title":"COST-FACIT analysis of cancer patients treated with radiotherapy in a publicly funded healthcare System in one country","volume":"120","author":"Skubic","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2026.104697_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4143\/crt.2021.784","article-title":"Validation of Korean version of the COmprehensive Score for financial Toxicity (COST) among breast cancer survivors","volume":"54","author":"Shim","year":"2022","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.breast.2026.104697_bib20","series-title":"EORTC QLQ-C30 scoring manual","author":"The","year":"2001"},{"key":"10.1016\/j.breast.2026.104697_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/jnci\/djac064","article-title":"Cancer's lasting financial burden: evidence from a longitudinal assessment","volume":"114","author":"Shih","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2026.104697_bib22","doi-asserted-by":"crossref","first-page":"e1094","DOI":"10.1200\/OP.20.00721","article-title":"Longitudinal trends of financial toxicity in patients with lung cancer: a prospective cohort study","volume":"17","author":"Friedes","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.breast.2026.104697_bib23","first-page":"437","article-title":"Navigating financial toxicity in patients with cancer: a multidisciplinary management approach","volume":"72","author":"Smith","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2026.104697_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0179","article-title":"Association of neighborhood-level household income with 21-Gene recurrence score and survival among patients with estrogen receptor\u2013positive breast cancer","volume":"6","author":"Ma","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.breast.2026.104697_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2026.104697_bib26","article-title":"Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies","volume":"356","author":"Batty","year":"2017","journal-title":"Bmj"},{"key":"10.1016\/j.breast.2026.104697_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/pon.5265","article-title":"Impact of fear of cancer recurrence on survival among lymphoma patients","volume":"29","author":"Kim","year":"2020","journal-title":"Psychooncology"},{"key":"10.1016\/j.breast.2026.104697_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pon.3418","article-title":"Social support, and mental health outcomes in patients with advanced cancer","volume":"23","author":"Applebaum","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.breast.2026.104697_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/OP.23.00716","article-title":"Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations","volume":"20","author":"Hart","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.breast.2026.104697_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102992","article-title":"ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer","volume":"9","author":"Carrera","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.breast.2026.104697_bib31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.34220","article-title":"Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery","volume":"128","author":"Corrigan","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2026.104697_bib32","first-page":"884","article-title":"Treatment-related adverse events as a source of financial hardship in young adults with breast cancer: a qualitative study","volume":"33","author":"Myers","year":"2025","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.breast.2026.104697_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1200\/OP.24.00172","article-title":"The price is NOT right: payers' roles in addressing financial toxicity","volume":"21","author":"Patel","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.breast.2026.104697_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/OP.24.00085","article-title":"Debt or dying: the high costs of cancer care in America, one patient's perspective","volume":"21","author":"Shanahan","year":"2025","journal-title":"JCO Oncol Pract"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762600007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762600007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:08:40Z","timestamp":1770998920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762600007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S096097762600007X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104697","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceived financial toxicity after active treatment and its association with clinical outcomes among breast cancer survivors: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104697"}}